|
![]() |
AltocorThis page contains recent news articles, when available, and an overview of Altocor but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Altocor (when available) Lovastatin, an antilipemic agent produced by fermentation of Aspergillus terreus, is the first of a class of lipid-lowering agents known as the HMG-CoA reductase inhibitors. Lovastatin is used to treat hypercholesterolemia, to slow coronary atherosclerosis, and to prevent myocardial infarction and stroke. Lovastatin, like simvastin and unlike pravastatin, is a prodrug, concentrating active drug in the liver during first-pass circulation. For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia; For primary prevention of coronary heart disease Mechanism Of Action: Lovastatin is a lactone that is readily hydrolyzed in vivo to the corresponding b-hydroxyacid, a potent inhibitor of HMG-CoA reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate. The conversion of HMG-CoA to mevalonate is an early step in the biosynthetic pathway for cholesterol. News Articles on Lovastatin Buy cheap Reyataz (atazanavir) Information , side effects, online ... - Jun 30, 2009 Altocor), simvastatin (Zocor), pimozide (Orap), midazolam (Versed), triazolam (Halcion), rifampin (Rifadin, Rimactane, Rifater), or St. John's wort. На плувка и дъно El Gobierno Municipal retira el Te Deum del programa del 24 ... - Mar 3, 2009 El Gobierno Municipal de El Alto admitió hoy que retiró la celebración del Te Deum del programa del 24 aniversario de creación de la ciudad de El Alto, La Razón (Bolivia) COR El Alto, prepara propuesta de sugerencias para control social ... - Feb 27, 2009 EL ALTO, feb 27.- Franklin Troche, secretario general de la Central Obrera Regional (COR) El Alto informó que esta organización esta trabajando un documento Noticias Bolivianas eabolivia.com Morales liegt mit den USA über Kreuz - Mar 1, 2009 Édgar Pantana von der Regionalen Arbeiterzentrale El Alto (COR) und Präsident der Departamentalen Koordination für den Wandel (CODELCAM), verwies auf die Neues Deutschland Can Drug Therapy Prevent Parkinson’s Disease? Aug 25, 2008 ...includes the well-known and often-prescribed atorvastatin (Lipitor), simvastatin (Zocor), lovastatin (Altocor, Mevacor), and pravastatin (Pravachol).GNIF Brain Blogger, Manufacturers Register Now for Free AmCon Expo in Grand Rapids Aug 27, 2008 Below is just a sample of some of the firms that attended last year: AAR Mobility Systems, Access Business Group, ADAC Automotive, Altocor, American AxleThe Open Press (press release) Grand Rapids Engineers and Buyers Plan AmCon Attendance September ... - Jul 22, 2008 Below is just a sample of some of the firms that attended last year: AAR Mobility Systems, Access Business Group, ADAC Automotive, Altocor, American Axle PR-USA.net (press release), Brand Names/Synonyms: Altocor is also known by the following brand names and/or synonyms: 6alpha-Methylcompactin; Altocor; Altoprev; Artein; Belvas; Cholestra; Closterol; Colevix; Compactin; HSDB 6534; Hipolip; Hipovastin; Lestatin; Lipdip; Lipivas; Lipofren; Lovalip; Lovalord; Lovastatin; Lovastatin [Usan:Ban:Inn]; Lovastatina [Spanish]; Lovastatine [French]; Lovastatinum [Latin]; Lovasterol; Lovastin; Lozutin; MK 803; MK-803; ML-530B; MSD 803; Mevacor; Mevastatin; Mevinacor; Mevinolin; Mevlor; Monacolin K; Nergadan; Paschol; Pravastatin; Rodatin; Rovacor; Sivlor; Taucor; Tecnolip; Teroltrat Drug Category: Altocor is categorized under the following by the FDA: Antineoplastic Agents; Anticholesteremic Agents; HMG-CoA Reductase Inhibitors; ATC:C10AA02 Dosage Forms: Tablet Absorption: 30% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: [8-[2-(4-hydroxy-6-oxo-oxan-2-yl)ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2-methylbutanoate |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |